Skip to main navigation
Mobia Medical homepage
  • Meet Mobia Medical
    • Our Mission
    • Our Leadership
    • Our Culture
    • Our Careers
  • Vivistim Therapy
    • Our Therapy
    • MRI & Safety Info
    • Visit Vivistim.com
  • Patient Impact
  • Contact Us
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financial Information
    • Corporate Governance
    • Investor Resources
Mobia Medical homepage
Contact Us
  • Meet Mobia Medical
    • Our Mission
    • Our Leadership
    • Our Culture
    • Our Careers
  • Vivistim Therapy
    • Our Therapy
    • MRI & Safety Info
    • Visit Vivistim.com
  • Patient Impact
  • Contact Us
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financial Information
    • Corporate Governance
    • Investor Resources
  • Privacy Policy
  • Compliance
  • Patents

Event Details

Second Quarter 2026 Earnings Conference Call

Aug 11, 2026 4:30 PM EDT

Webcast
Add to Outlook
Add to Google Calendar

News & Events

  • Press Releases
  • Events
  • Presentations

Investor Contact

Louisa Smith
Gilmartin Group, LLC
investors@mobia.com

Subscribe to our email alerts

Mobia Medical logo

Meet Mobia

  • Our Mission
  • Our Leadership
  • Our Culture
  • Our Careers

Vivistim Therapy

  • Our Therapy
  • MRI & Safety Info
  • Visit Vivistim.com
  • Patient Impact
  • Contact Us
  • Investors

The Vivistim® Paired VNS™ System (Vivistim) is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. Do not use if you have had a bilateral or left cervical vagotomy. Risks may include, but are not limited to pain after surgery, hoarseness, bruising, swelling, coughing and throat irritation. While not observed with Vivistim, infection is a risk associated with surgery. For full safety information, please see www.vivistim.com/safety. Individual results may vary.

© 2026 Mobia Medical. All rights reserved. Serenity, Vivistim, Paired VNS, and the Mobia Medical logo are trademarks of Mobia Medical.

  • Privacy Policy
  • Compliance
  • Patents